Stay updated on BeGeRN Clinical Trial

Sign up to get notified when there's something new on the BeGeRN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BeGeRN Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The record describes the BeGeRN phase I/II trial of bendamustine, gemcitabine, rituximab, and nivolumab for relapsed or refractory diffuse large B-cell lymphoma, including its treatment arms, eligibility criteria, and outcome measures. The study is completed and is no longer recruiting.
    Difference
    59%
    Check dated 2026-11-08T13:23:39.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0; the study page remains inaccessible with a 403 Forbidden message.
    Difference
    0.2%
    Check dated 2026-11-01T14:38:07.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and says the agency is transitioning from the term “Artificial Intelligence” to “Super Intelligence,” with links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T13:44:02.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.1 to v3.7.2; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T13:52:00.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T14:48:57.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now shows a 403 error page with minimal navigation, and the detailed study content and related sections are no longer accessible. This makes the BeGeRN/DLBCL study record effectively unavailable to users.
    Difference
    20%
    Check dated 2026-09-20T19:52:20.000Z thumbnail image

Stay in the know with updates to BeGeRN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BeGeRN Clinical Trial page.